C6 NBD Galactosylceramide (d18:1/6:0) (Synonyms: N-hexanoylNBD-Galactosylceramide, C6 NBD Galactosylceramide, NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer, NBD GalCer(d18:1/6:0)) |
| Katalog-Nr.GC43098 |
C6-NBD-Galactosylceramid ist ein aktives Derivat von Galactosylceramid, das mit fluoreszierendem C6-Nitrobenzoxadiazol (C6-NBD) markiert ist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 170212-26-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
C6 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C6 nitrobenzoxadiazole group. C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, a sphingolipid whose synthesis is disrupted in Krabbe disease due to a deficiency of galactosylceramide β-galactosidase.
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *